[1] SOONPAA M H,FIELD L J.Survey of studies examining mammalian cardiomyocyte DNA synthesis[J].Circ Res,1998,83(1):15-26.
[2] BERGMANN O,BHARDWAJ R D,BERNARD S,et al.Evidence for cardiomyocyte renewal in humans[J].Science,2009,324(5923):98-102.
[3] 陈曦,刘志勇.心脏干细胞及其应用研究进展[J].东南大学学报:医学版,2009,28(6):544-546.
[4] D'AMARIO D,FIORINI C,CAMPBELL P M,et al.Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies[J].Circ Res,2011,108(7):857-861.
[5] DAWN B,STEIN A B,URBANEK K,et al.Cardiac stem cell delivered intravascularly traverse the vessel barrier,regenerate infarcted myocardium,and improve cardiac function[J].Proc Natl Acad Sci U S A,2005,102(10):3766-3771.
[6] LINKE A,MVLLER P,NURZYNSKA D,et al.Stem cells in the dog heart are self-renewing,clonogenic,and multipotent and regenerate infarcted myocardium,improving cardiac function[J].Proc Natl Sci USA,2005,102(25):8966-8971.
[7] CHOI S H,JUNG S Y,SUH W,et al.Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy[J].Transplant Proc,2013,45(1):420-426.
[8] RÖNNSTRAND L.Signal transduction via the stem cell factor receptor/c-Kit[J].Cell Mol Life Sci,2004,61(19-20):2535-2548.
[9] ZHANG G W,WEN T,GU T X,et al.Transmyocardial drilling revascularization combined with heparinized bFGF-incorporating stent activates resident cardiac stem cells via SDF-1/CXCR4 axis[J].Exp Cell Res,2012,318(4):391-399.
[10] TANG Y L,ZHU W,CHENG M,et al.Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression[J].Circ Res,2009,104(10):1209-1216.
[11] CHENG M,ZHOU J,WU M,et al.CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity[J].Circ Res,2010,107(9):1083-1093.
[12] FAZEL S,CIMINI M,CHEN L,et al.Cardioprotective c-kit+cell s are f rom the bone marrow and regulate t he myocardial balance of angiogenic cytokines[J].Clin Invest,2006,116(7):1865-1877.
[13] URBANEK K,TORELLA D.Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure[J].Proc Natl Acad Sci U S A,2005,102(24):8692-8697.
[14] MÖHLE R,MOORE M A,NACHMAN R L,et al.Transendothelial migration of CD34+and mature hematopoietic cells:an in vitro study using a human bone marrow endothelial cell line[J].Blood,1997,89(1):72-80.
[15] 孟晨,吴小涛.SDF-1/CXCR4信号轴在调节干细胞迁移及发育中的作用[J].东南大学学报:医学版,2011,30(4):625-629.
[16] KORTESIDIS A,ZANNETTINO A,ISENMANN S,et al.Stromal-derived factor-1 promotes the growth,survival,and development of human bone marrow stromal stem cells[J].Blood,2005,105(10):3793-3801.
[17] PILLARISETTI K,GUPTA S K.Cloning and relative expression analysis of rat stromal cell derived factor-1(SDF-1)1:SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction[J].Inflammation,2001,25(5):293-300.
[18] ZHANG G,NAKAMURA Y,WANG X,et al.Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+cell homing to the infarcted heart[J].Tissue Eng,2007,13(8):2063-2071.
[19] FRICKER S P,ANASTASSOV V,COX J,et al.Characterization of the molecular pharmacology of AMD3100:a specific antagonist of the G-protein coupled chemokine receptor,CXCR4[J].Biochem Pharmacol,2006,72(5):588-596.
[20] STAMATOPOULOS B,MEULEMAN N,de BRUYN C,et al.AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment:preclinical evidence for its association with chronic lymphocytic leukemia treatments[J].Haematologica,2012,97(4):608-615. |